Plain-English translation of NCT07556133 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
During cataract surgery, patients need medication to help them relax and stay still. This trial is testing three different combinations of sedation drugs—including dexmedetomidine, propofol, and fentanyl—to see which combination keeps patients most comfortable, maintains the safest heart rate and blood pressure, and leads to the quickest recovery. The goal is to find the best recipe of medications for this common eye surgery.
Cataract surgery is one of the most common procedures in the world, especially for older patients. While the surgery itself uses local numbing, many patients need extra sedation to feel calm and avoid moving. Doctors use different sedation combinations, but we don't yet know which one is truly the safest and most effective—so this trial will help answer that question.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to receive one of three sedation combinations during your cataract surgery. The medical team will give you the sedation medications through an IV, monitor your comfort level and vital signs (heart rate, blood pressure, oxygen) during the procedure, and watch you recover afterward. Your participation mainly involves receiving the assigned sedation and allowing the team to track how well it works.
AI-generated summary from trial data · Jun 16, 2026 · Not medical advice
Lebanon
Sponsor
Saint-Joseph University
Enrollment target
~1,000 participants
Started
November 2025
Primary completion
November 2026
Age range
18 Years and older
Last updated on clinicaltrials.gov in April 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Rhea Nacouzi, MD
Hotel Dieu de France Hospital, Beirut, Lebanon
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.